NRSN icon

NeuroSense Therapeutics
NRSN

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8.5
1,029% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Roth Capital
Roth Capital
Boobalan Pachaiyappan
0% 1-yr NRSN win rate
10 Mar ‘26 12 days ago
D. Boral Capital
D. Boral Capital
Jason Kolbert
33% 1-yr NRSN win rate
9 Mar ‘26 13 days ago